Skip to main content
. 2015 Jul 1;10(3):1709–1715. doi: 10.3892/ol.2015.3442

Figure 4.

Figure 4.

Kaplan-Meier cancer-specific survival curves for 86 patients with breast carcinoma, grouped according to their SMAD4 expression status. SMAD4-negative patients had a significantly reduced overall survival rate compared with that of SMAD4-positive patients (P=0.008).